142 related articles for article (PubMed ID: 32483731)
1. Aerosolized Chemotherapy for Osteosarcoma.
Gordon N; Felix K; Daw NC
Adv Exp Med Biol; 2020; 1257():67-73. PubMed ID: 32483731
[TBL] [Abstract][Full Text] [Related]
2. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
3. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
[TBL] [Abstract][Full Text] [Related]
4. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
Gordon N; Kleinerman ES
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
[TBL] [Abstract][Full Text] [Related]
5. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
Koshkina NV; Kleinerman ES
Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
[TBL] [Abstract][Full Text] [Related]
6. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
Dhupkar P; Gordon N
Adv Exp Med Biol; 2017; 995():33-51. PubMed ID: 28321811
[TBL] [Abstract][Full Text] [Related]
8. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized chemotherapy.
Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
[TBL] [Abstract][Full Text] [Related]
10. Aerosol Delivery of Interleukin-2 in Combination with Adoptive Transfer of Natural Killer Cells for the Treatment of Lung Metastasis: Methodology and Effect.
Kiany S; Gordon N
Methods Mol Biol; 2016; 1441():285-95. PubMed ID: 27177675
[TBL] [Abstract][Full Text] [Related]
11. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
Gordon N; Kleinerman ES
Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
[TBL] [Abstract][Full Text] [Related]
12. Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung.
Chou AJ; Gupta R; Bell MD; Riewe KO; Meyers PA; Gorlick R
Pediatr Blood Cancer; 2013 Apr; 60(4):580-6. PubMed ID: 23255417
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
Kleinerman ES; Gano JB; Johnston DA; Benjamin RS; Jaffe N
Am J Clin Oncol; 1995 Apr; 18(2):93-9. PubMed ID: 7900714
[TBL] [Abstract][Full Text] [Related]
14. Caffeine-potentiated chemotherapy for metastatic osteosarcoma.
Kimura H; Tsuchiya H; Shirai T; Nishida H; Hayashi K; Takeuchi A; Ohnari I; Tomita K
J Orthop Sci; 2009 Sep; 14(5):556-65. PubMed ID: 19802667
[TBL] [Abstract][Full Text] [Related]
15. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
Knight V; Kleinerman ES; Waldrep JC; Giovanella BC; Gilbert BE; Koshkina NV
Ann N Y Acad Sci; 2000; 922():151-63. PubMed ID: 11193890
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
18. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma: review of the past, impact on the future. The American experience.
Jaffe N
Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
[TBL] [Abstract][Full Text] [Related]
20. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]